Sort
17,054 grants matching “genome editing”
Defining driver tumor-suppressors for melanoma using the zebrafish
$171,990Julien Ablain · Boston Children'S Hospital · K99 · FY2016 · CA
Defining driver tumor-suppressors for melanoma using the zebrafish
$171,990Julien Ablain · Boston Children'S Hospital · K99 · FY2017 · CA
Genetic variation impacting the airway smooth muscle in children with asthma
$171,882Walter Eckalbar · University Of California, San Francisco · K99 · FY2017 · HL
Genetic variation impacting the airway smooth muscle in children with asthma
$171,816Walter Eckalbar · University Of California, San Francisco · K99 · FY2018 · HL
Genome Editing Shared Resource
$171,743Mark A Magnuson · Vanderbilt University Medical Center · P30 · FY2022 · CA
Genome Editing Shared Resource
$171,743Mark A Magnuson · Vanderbilt University Medical Center · P30 · FY2024 · CA
Genome Editing Shared Resource
$171,743Mark A Magnuson · Vanderbilt University Medical Center · P30 · FY2023 · CA
Genome Editing Shared Resource
$171,743Mark A Magnuson · Vanderbilt University Medical Center · P30 · FY2021 · CA
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome
$171,720Theodoros Karantanos · Johns Hopkins University · K08 · FY2025 · HL
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
$171,720Marios Arvanitis · Johns Hopkins University · K08 · FY2024 · HL
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
$171,720Marios Arvanitis · Johns Hopkins University · K08 · FY2025 · HL
Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer
$171,720Yuan-Hung Lo · Stanford University · K99 · FY2022 · CA
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome
$171,720Theodoros Karantanos · Johns Hopkins University · K08 · FY2023 · HL
Functional characterization of novel oncogenic loci driving progression and immune response in gastrointestinal cancer
$171,720Yuan-Hung Lo · Stanford University · K99 · FY2021 · CA
CCRL2 as a Regulator of Growth and Novel Target in Myelodysplastic Syndrome
$171,720Theodoros Karantanos · Johns Hopkins University · K08 · FY2024 · HL
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
$171,720Marios Arvanitis · Johns Hopkins University · K08 · FY2023 · HL
Investigating the Mechanisms of Cohesinopathy in Myelodysplastic Syndromes
$171,720Zuzana Tothova · Dana-Farber Cancer Inst · K08 · FY2019 · HL
Administrative Core
$171,700Dean F. Bajorin · Sloan-Kettering Inst Can Research · P50 · FY2018 · CA
DNA damage response and repair of a broken chromosome
$171,563James E Haber · Brandeis University · R35 · FY2021 · GM
Transgenic and Targeted Mutagenesis Laboratory Shared Resource
$171,413Rajeshwar B Awatramani · Northwestern University At Chicago · P30 · FY2021 · CA
Transgenic and Targeted Mutagenesis Laboratory Shared Resource
$171,413Rajeshwar B Awatramani · Northwestern University At Chicago · P30 · FY2020 · CA
Transgenic and Targeted Mutagenesis Laboratory Shared Resource
$171,413Rajeshwar B Awatramani · Northwestern University At Chicago · P30 · FY2022 · CA
Transgenic and Targeted Mutagenesis Laboratory Shared Resource
$171,413Rajeshwar B Awatramani · Northwestern University At Chicago · P30 · FY2019 · CA
Genome Editing Shared Resource
$171,292Mark A Magnuson · Vanderbilt University Medical Center · P30 · FY2020 · CA
Target Validation Core
$171,057Xu Luo · University Of Nebraska Medical Center · P20 · FY2021 · GM